Provider review
RxSpan MD review
All-inclusive monthly pricing for injections and capsules, with no microdose product.
A small dose is a lower prescription inside a standard plan, so it costs what a full dose does.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
$249/mo month to month ($199 on 6-mo)
Visit RxSpan MDPrice as published
RxSpan MD
$249/mo month to month ($199 on 6-mo)
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Taking less costs the same here. RxSpan MD has no microdose product, so a small dose is a lower prescription inside a standard plan at the standard price. What it does well is make that price a real one. The consult, medication, supplies, shipping and support all sit inside a single figure, and every compounded product can be bought month to month, so you are not forced into a prepay to see what a month costs. Both molecules come as oral capsules as well as injections, and the brand-name pens carry a first-month price on the page. The cost of misreading it is in the headline rate. The lowest figure needs a 12-month plan paid in one go with a launch promo, and that plan renews automatically. You also pay before a provider reviews you. Its own comparison page says compounded capsules cannot be assumed to work like approved tablets, which is a fair warning to read before choosing them.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want one figure with nothing billed beside it, and a month-to-month option
- You want a capsule rather than an injection, with a published price
- You want brand-name pens priced before you sign up
Look elsewhere if
- You want to pay less for taking less: there is no low-dose product
- You want certainty before paying: eligibility is reviewed after checkout
- You want the headline rate without a 12-month plan that renews itself
What it actually costs
Price as published
$249/mo month to month ($199 on 6-mo)
- Vs median
- $80/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
159 of the 407 programs here price a small dose this way. No microdose product on its weight-loss pages, so a small dose is a lower prescription inside a standard plan. Every compounded product is priced all-inclusive and sold month to month as well as on longer plans.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Optional
- Pricing
- Varies by dose, plan or tier
What it does well
- One all-inclusive price covering the consult, medication, supplies, shipping and support
- A month-to-month plan for every compounded product, so a prepay is optional
- Oral capsules of both molecules as well as injections
- Brand-name Ozempic, Wegovy and Zepbound priced on the page rather than after intake
- Unlimited messaging and appointments with the care team
Pharmacy, labs and oversight
RxSpan MD does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What RxSpan MD publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
RxSpan MD is a LegitScript-certified telehealth practice whose weight-loss evidence pages are written by Dr. John Diaz. It sells compounded semaglutide and tirzepatide as weekly injections and as oral capsules, and brand-name Ozempic, Wegovy and Zepbound with a first-month price printed beside each. Every compounded price includes the consult, medication, supplies, shipping and support, and each comes month to month or prepaid for three, six or twelve months, at a lower rate the longer you commit. The 12-month plan is billed as one payment and renews automatically, and CareCredit financing is offered. You pay at checkout, and a provider then decides whether to prescribe. Messaging and appointments with the care team are unlimited. There is no microdose product on its weight-loss pages, so a small dose is a lower prescription inside a standard plan, at the standard price. Its own comparison page says compounded capsules cannot be assumed to work like approved tablets.
The honest cons
No microdose product: a small dose costs the same as a full one inside a standard plan
- The lowest advertised rate needs a 12-month plan paid up front with a launch promo, and that plan renews automatically
- You pay before a provider reviews you, and a prescription is not guaranteed
- Its own page says compounded capsules cannot be assumed to match approved oral tablets
- Compounded semaglutide and tirzepatide are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
RxSpan MD is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Where this sits
#6 of 407
Ordered with the companies that pay us first, and RxSpan MD is one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Oral semaglutide (Rybelsus)
- What microdosing GLP-1 costs
- What the evidence actually shows
- Microdose & reconstitution calculator
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $21/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.